Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Clinical trial NCT01479244 · COMPLETED
Trial details
- NCT number
- NCT01479244
- Sponsor
- Galena Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2016-09-21
- Enrollment
- 758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.